TickerFacts.

UL Solutions Inc. (ULS): Net Income

Annual figures by period end, from SEC filings.

$325.00M
Year ended 2025-12-31
$506.00M
Trailing 12 months to 2026-06-30
+3.5%
3-year compound annual growth
$326.00M2022-12-31: $293.00M2023-12-31: $260.00M2024-12-31: $326.00M2025-12-31: $325.00M$325.00M
2022-12-31 Net Income (USD) 2025-12-31
Period endedNet IncomeChange YoYSource filing
2025-12-31$325.00M-0.3%2026-02-19, From 2025-01-01
2024-12-31$326.00M+25.4%2026-02-19, From 2024-01-01
2023-12-31$260.00M-11.3%2026-02-19, From 2023-01-01
2022-12-31$293.00Mn/a2025-02-20, From 2022-01-01

Net Income at similar companies

Companies with the same SEC industry code (Services-Testing Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedNet IncomeChange YoY
UL Solutions Inc. (ULS)2025-12-31$325.00M-0.3%
NeoGenomics Inc (NEO)2025-12-31-$108.03Mn/m
20/20 Biolabs, Inc. (AIDX)2025-12-31-$3.74Mn/m
Hypha Labs, Inc. (FUNI)2025-09-30-$3.10Mn/m

Compare ULS, NEO, AIDX, FUNI side by side · Screen every company in Services-Testing Laboratories ↗